DavidWalkMD

Neurology • Minneapolis, MN

Neuromuscular Medicine, Neurophysiology

Associate Professor, Neurology, University of Minnesota Medical School

Join to view full profile

Dr. Walk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Walk's full profile

Already have an account?

Office
516 Delaware St SE
# Pwb
Minneapolis, MN 55455
Phone+1 612-626-3004

Fax+1 612-273-4098

Education & Training

University of ChicagoResidency, Neurology, 1986 - 1989
McGaw Medical Center of Northwestern UniversityInternship, Transitional Year, 1984 - 1985
The Warren Alpert Medical School of Brown UniversityClass of 1984

Certifications & Licensure

IL State Medical License 1986 - 2026
MN State Medical License 1999 - 2025
CT State Medical License 2021 - 2022
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Clinical Neurophysiology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com

Clinical Trials

International Guillain-Barré Syndrome Outcome Study Start of enrollment: 2012 May 01
Active, not recruiting

Publications & Presentations

PubMed

1 citations
TRPV4 neuromuscular disease registry highlights bulbar, skeletal and proximal limb manifestations.
Gage Kosmanopoulos, Jack K Donohue, Maya Hoke, Simone Thomas, Margo A Peyton
Brain. 2024-06-25
Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A.
Shahram Attarian, Peter Young, Thomas H Brannagan, David Adams, Philip Van Damme
Orphanet Journal of Rare Diseases. 2024-04-01
8 citations
Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variants.
Christopher J Record, Mariola Skorupinska, Matilde Laura, Alexander M Rossor, Davide Pareyson
Brain. 2023-10-03

Press Mentions

Acceleron Announces Plans to Initiate a Phase 2 Trial of ACE-083 in Charcot-Marie-Tooth Neuromuscular Disease and Host Educational WebinarMarch 16th, 2017